Ohio State Navbar

New Study Published in New England Journal of Medicine


A new study outlining resistance mechanisms to Ibrutinib therapy has been published in the New England Journal of Medicine.  Led by Dr. Jennifer Woyach, the study identifies gene mutations that can lead to Ibrutinib resistance in patients.  Knowledge of these mutations will help lead to future combined therapies to prevent or treat Ibrutinib resistance in CLL patients.

 

Please click here to read the published study.